Ein System für zellbasierten Screening

European patent · EP1314980 · Deleted

Register entry

Publication number
EP1314980
Application number
EP03004224
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Feb 25, 2000
Published
May 28, 2003
Granted
Dec 9, 2009
Deleted
Feb 24, 2020
Reason
Maximum term reached
IPC classes
G01N 15/14 (2006.01)
G01N 33/50 (2006.01)
C12M 1/34 (2006.01)
Priority
US 122152 P 26.02.1999
US 123399 P 08.03.1999
US 352171 12.07.1999
Divided from
EP00914701
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 3, 2020

    Maximum term reached

    Published in Swissreg on 03.03.2020

  2. Mar 31, 2010

    Address changed

    Owner
    Cellomics, Inc., 635 William Pitt Way, Pittsburgh, PA 15238, USA → Cellomics, Inc., 100 Technology Drive, Pittsburgh, PA 15219-3130, USA

    Published in Swissreg on 31.03.2010

  3. Jan 20, 2010

    Agent entered

    Representative
    Hans Ulrich Seifert, Seifert & Partner, Pestalozzistrasse 2 /Postfach 1416, 8201 Schaffhausen

    Published in Swissreg on 20.01.2010

  4. Dec 9, 2009

    Granted

    Published in Swissreg on 09.12.2009

Parties

Holder

Cellomics Inc.

Cellomics, Inc.

100 Technology Drive, Pittsburgh, PA 15219-3130, US

Agent

Hans Ulrich Seifert Seifert & Partner

Pestalozzistrasse 2 /Postfach 1416, 8201 Schaffhausen

Inventor

Giuliano, Kenneth, A.

Pittsburgh, PA 15209, US

Kapur, Ravi

Gibsonia, PA 15044, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.